title: Tocilizumab ameliorates clinical symptoms in polymyalgia rheumatica.
authors.forename: Keisuke
authors.initials: K
authors.lastname: Hagihara
authors.forename: Ichiro
authors.initials: I
authors.lastname: Kawase
authors.forename: Toshio
authors.initials: T
authors.lastname: Tanaka
authors.forename: Tadamitsu
authors.initials: T
authors.lastname: Kishimoto
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D011111:Polymyalgia Rheumatica / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; C502936:tocilizumab